Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,666.3
-3.2 (-0.12%)

 

  • STI Straits Times Index
    2,666.3
    -3.2 (-0.12%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,583.5
    -0.1
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,354.1
    224.9 (0.86%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,426.2
    22.8 (0.67%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,491.3
    52.6 (0.23%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,076.2
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 642.9M
  • Value: 239.0M
  • Rise: 112
  • Fall: 86
  • Unch: 610

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
AsiaMedic0.034+0.014
QT Vascular0.006+0.001
Singapore-eDev0.134+0.001
3Cnergy0.020+0.003
Medtecs Intl0.880+0.060
Thomson Medical0.061+0.002
Healthway Med0.038+0.003
Adventus0.023+0.003
Clearbridge0.179+0.007
SingMedical0.265+0.010

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NOVOCURE LTD NOVOCURE LTD
Updated on 08 Jul 2020 (End of trading day)
Last (USD): 60.970 Change: +1.390 High: 61.100 Remarks: -
Change (%): +2.33 Low: 59.370
Open 59.370 Yesterday's Close 59.58
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 856,154 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.07198 Trailing EPS (USD) e 0.08833 NAV (USD) b 2.4089
PE a - Trailing PE f 690.242 Price / NAV b 25.3103
Dividend (USD) d - Cash In Hand (USD) g 1.8190 Issued & Paid-up Shares c 100,440,000
Dividend Yield (%) d - Price / Cash In Hand g 33.518 Treasury Shares h -
Market Cap (M) 6,123.827 Enterprise Value (M) 5,954.512
Piotroski F Score 6 Exchange Code NVCR Par Value ( $ ) n.a.
52 Weeks Volatility (%) 56.26 Free Float (%) 82.6
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 30 Apr 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 28 Sep 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NOVOCURE LTD NASDAQ 6,123.827 - 690.242 25.3103 -
Industry Medical Specialties NASDAQ 2,365.688 404.952 111.839 8.1690 0.038
Local Peer INTUITIVE SURGICAL INC NASDAQ 67,750.393 49.119 48.871 7.9644 -
Local Peer DEXCOM INC NASDAQ 40,160.653 397.237 271.539 42.9755 -
Local Peer IDEXX LABORATORIES INC NASDAQ 28,547.680 66.744 65.347 265.1207 -
Local Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 23,028.142 70.920 173.867 10.8772 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 21,926.804 49.521 11.607 7.6856 -
Local Peer HOLOGIC INC NASDAQ 14,877.830 - 24.144 7.1319 -
Local Peer INSULET CORPORATION NASDAQ 13,668.079 1,178.249 2,651.936 231.6676 -
Local Peer MASIMO CORPORATION NASDAQ 12,689.520 64.671 60.040 10.1250 -
Local Peer ABIOMED INC NASDAQ 11,965.515 58.941 58.941 11.2303 -
Local Peer DENTSPLY SIRONA INC NASDAQ 9,201.360 34.999 109.801 1.9630 0.902
Local Peer QUIDEL CORP NASDAQ 9,973.923 136.777 112.937 16.4805 -
Local Peer BRUKER CORPORATION NASDAQ 6,363.530 32.269 35.972 6.9501 0.388
Other Local Peers TANDEM DIABETES CARE INC (NASDAQ), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), NUVASIVE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), LIVANOVA PLC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), INARI MEDICAL INC (NASDAQ), ATRICURE INC (NASDAQ), CAREDX INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), INMODE LTD (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ZYNEX INC (NASDAQ), HESKA CORP (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), INOGEN INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), SURMODICS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SI BONE INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), AXOGEN INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), VIEWRAY INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), PROFOUND MED CORP (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), MISONIX INC (NASDAQ), CUTERA INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), DERMTECH INC (NASDAQ), SIENTRA INC (NASDAQ), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), SOLITON INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), FONAR CORP (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), CELSION CORPORATION (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), CONFORMIS INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), TITAN MEDICAL INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), IMMUCELL CORP (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), NEOVASC INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), NEURONETICS INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), ELECTROCORE INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), IRIDEX CORP (NASDAQ), NEUROTROPE INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), CHF SOLUTIONS INC (NASDAQ), BIOLASE INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), AVINGER INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), DIGIRAD CORP (NASDAQ), CYANOTECH CORP (NASDAQ), DYNATRONICS CORP (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ENDOLOGIX INC (NASDAQ), NEUROMETRIX INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Global Peer ABBOTT LABORATORIES NYSE 163,760.133 44.670 46.273 5.4193 1.421
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 152,699.905 41.315 41.619 5.3468 0.198
Global Peer DANAHER CORP NYSE 130,651.796 52.496 47.735 4.4356 0.362
Global Peer MEDTRONIC PLC NYSE 122,876.493 25.658 25.658 2.4218 2.357
Global Peer BECTON DICKINSON & CO NYSE 71,643.648 66.214 78.729 3.4199 1.170
Global Peer STRYKER CORP NYSE 68,132.486 32.709 31.485 5.1950 1.174
Global Peer BOSTON SCIENTIFIC CORP NYSE 49,362.622 10.503 11.514 3.5760 -
Global Peer BAXTER INTERNATIONAL INC NYSE 42,833.814 42.791 41.953 5.5636 1.004
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 42,960.931 32.891 32.891 3.0382 1.910
Global Peer EDWARDS LIFESCIENCES CORP NYSE 42,608.097 40.699 38.462 10.9221 -
Other Global Peers ALCON AG (NYSE), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), HARTA (Bursa), TOPGLOV (Bursa), STERIS PLC (NYSE), Top Glove (SGX), WATERS CORP (NYSE), WEIGAO GROUP (HKEx), PERKINELMER INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), QIAGEN NV (NYSE), MICROPORT (HKEx), COCHLEAR LTD (ASX), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), KANGJI MEDICAL (HKEx), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), GLOBUS MED INC (NYSE), NEVRO CORP (NYSE), AK MEDICAL (HKEx), ENVISTA HOLDINGS CORPORATION (NYSE), SUPERMX (Bursa), PEIJIA-B (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), EBOS GROUP (ASX), CONMED CORP (NYSE), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), KDL MEDICAL (HKEx), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), LIFETECH SCI (HKEx), VAPOTHERM INC (NYSE), CIRC (HKEx), CRYOLIFE INC (NYSE), INFUSYSTEM HOLDINGS INC (NYSE American), YESTAR HEALTH (HKEx), MCP INCOME OPPORTUNITIES TRUST (ASX), PW MEDTECH (HKEx), CORMEDIX INC (NYSE American), MEDICAL DEVELOPMENT INTL (ASX), STEREOTAXIS INC (NYSE American), GOLDEN MEDITECH (HKEx), Medtecs Intl (SGX), ALPHA PRO TECH (NYSE American), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), UG Healthcare (SGX), INVACARE CORP (NYSE), RETRACTABLE TECHNOLOGIES INC (NYSE American), VINCENT MED (HKEx), MODERN DENTAL (HKEx), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), VOLITIONRX LIMITED (NYSE American), CYCLOPHARM LIMITED (ASX), RESAPP HEALTH LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), SOMNOMED LIMITED (ASX), NOVA EYE MEDICAL LIMITED (ASX), YUNNAN ENERGY (HKEx), MILESTONE SCIENTIFIC INC (NYSE American), DAXOR CORP (NYSE American), LKL (Bursa), Biolidics (SGX), SDI LTD (ASX), COMPUMEDICS (ASX), IMPEDIMED LIMITED (ASX), DIMERIX LTD (ASX), RESONANCE HEALTH LTD (ASX), KELFRED (HKEx), RESPIRI LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), ONCOCYTE CORP (NYSE American), MICRO-X LTD (ASX), Yunnan Energy (SGX), OVENTUS MEDICAL LTD (ASX), LBT INNOVATIONS LTD (ASX), INCANNEX HEALTHCARE LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), METALICITY LIMITED (ASX), USCOM LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), LIFE HEALTHCARE (HKEx), XTANT MEDICAL HLDGS INC (NYSE American), RA MEDICAL SYSTEMS INC (NYSE), OPTISCAN IMAGING (ASX), CARDIEX LTD (ASX), Annica (SGX), ADHERIUM LIMITED (ASX), HUAKANG BIOMED (HKEx), STHAI (SET), ANALYTICA (ASX), DORSAVI LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+1.360
+2.28 %
10 Days -+1.620
+2.73 %
20 Days --6.920
-10.19 %
Medium Term Return 3 Months --8.530
-12.27 %
6 Months --18.710
-23.48 %
1 Year --4.350
-6.66 %
Long Term Return 2 Years -+27.620
+82.82 %
3 Years -+41.070
+206.38 %
Annualised Return Annualised --
+45.24 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 53.400 - 98.841 Change From 1 Year Low +7.570 % Change From 1 Year Low (%) +14.18
Change From 1 Year High -37.871 % Change From 1 Year High (%) -38.32
2 Years Range 26.020 - 98.841 Change From 2 Years Low +34.950 % Change From 2 Years Low (%) +134.32
Change From 2 Years High -37.871 % Change From 2 Years High (%) -38.32
5 Years Range 5.950 - 98.841 Change From 5 Years Low +55.020 % Change From 5 Years Low (%) +924.71
Change From 5 Years High -37.871 % Change From 5 Years High (%) -38.32
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

Historical Price Data

Date Open High Low Close Volume VWAP
07 Jul 2020 62.550 62.730 59.400 59.580 680,297 -
06 Jul 2020 61.130 63.350 60.760 62.860 796,647 -
02 Jul 2020 60.700 60.970 59.470 60.650 746,844 -
01 Jul 2020 59.890 60.420 59.280 59.610 766,693 -
30 Jun 2020 57.900 59.350 57.464 59.300 798,593 -
29 Jun 2020 59.540 59.815 57.325 57.700 944,937 -
26 Jun 2020 56.980 60.330 56.400 58.960 10,489,540 -
25 Jun 2020 59.120 59.340 56.220 57.200 1,726,756 -
24 Jun 2020 62.360 62.360 59.000 59.350 1,244,809 -
23 Jun 2020 63.430 63.560 62.100 62.760 1,058,827 -
22 Jun 2020 63.420 63.800 62.073 62.980 777,146 -
19 Jun 2020 63.000 64.720 62.365 63.370 1,043,960 -
18 Jun 2020 62.630 63.586 61.830 62.510 753,496 -
17 Jun 2020 65.670 65.870 62.760 62.920 934,746 -
16 Jun 2020 66.860 66.860 64.000 65.360 578,247 -
15 Jun 2020 62.520 65.600 61.330 65.320 808,590 -
12 Jun 2020 66.450 67.250 62.300 63.760 816,736 -
11 Jun 2020 65.710 67.378 63.630 65.030 1,273,166 -
10 Jun 2020 68.540 68.987 66.725 67.890 657,666 -
09 Jun 2020 69.990 70.110 68.050 68.340 815,803 -
08 Jun 2020 68.570 70.115 67.450 70.115 1,070,096 -
05 Jun 2020 62.820 68.700 61.740 68.150 1,331,272 -
Summary
Current 2 Weeks
(23 Jun 2020 to 07 Jul 2020)
63.430 63.560 56.220 59.580 19,253,943 -
Previous 2 Weeks
(09 Jun 2020 to 22 Jun 2020)
69.990 70.110 56.220 62.980 8,459,556 -
4 Weeks from
(11 May 2020 to 08 Jun 2020)
61.990 65.460 56.220 70.115 17,298,378 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.